CAV1 and Other metabolic disease: Hence, because of the impact of the CAV-1 gene with oxidative stress, it seems that adherence to hPDI could be capable of lowering the metabolic markers, and, as a result, reducing the likelihood of metabolic diseases in women with obesity carrying a risk the allele of ‘A’.